Gilles Pernod Selected Research

Gilles Pernod Research Topics

Disease

21	Hemorrhage 01/2024 - 12/2009
13	Venous Thromboembolism 01/2024 - 07/2009
13	Pulmonary Embolism 11/2022 - 02/2008
13	Venous Thrombosis (Deep-Vein Thrombosis) 07/2022 - 12/2006
7	Thrombosis (Thrombus) 01/2021 - 01/2005
5	Atrial Fibrillation 01/2024 - 12/2011
4	Neoplasms (Cancer) 01/2022 - 07/2011
3	Thrombocytopenia (Thrombopenia) 01/2021 - 01/2019
3	Anemia 07/2018 - 01/2004
2	Peripheral Arterial Disease 10/2023 - 04/2020
2	COVID-19 11/2022 - 01/2021
2	Thromboembolism 01/2022 - 01/2019
2	Ischemia 04/2021 - 04/2020
2	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 12/2018 - 09/2012
2	Chronic Limb-Threatening Ischemia 10/2017 - 08/2017
2	Edema (Dropsy) 03/2017 - 07/2011
2	Embolism (Embolus) 02/2014 - 06/2013
2	Chronic Kidney Failure (Chronic Renal Failure) 10/2011 - 01/2004
2	Hyperhomocysteinemia 10/2009 - 01/2004
1	Hypertriglyceridemia 10/2023
1	Lung Diseases (Lung Disease) 11/2022
1	Postthrombotic Syndrome 07/2022
1	Pathologic Constriction (Stenosis) 04/2021
1	Heart Diseases (Heart Disease) 04/2021
1	Seizures (Absence Seizure) 01/2021
1	Intracranial Sinus Thrombosis (Sinus Thrombosis) 01/2021
1	Ulcer 09/2017
1	Multiple Chronic Conditions 09/2017
1	Hyperpigmentation 03/2017
1	Obesity 03/2017
1	Rare Diseases (Rare Disease) 09/2012
1	Hypoprothrombinemias (Prothrombin Deficiency) 09/2012
1	Stroke (Strokes) 12/2011
1	Hemophilia A (Haemophilia) 04/2006
1	Acute Liver Failure (Fulminant Hepatic Failure) 01/2005
1	Myocardial Ischemia (Ischemic Heart Diseases) 01/2005
1	Liver Diseases (Liver Disease) 01/2005

Drug/Important Bio-Agent (IBA)

19	AnticoagulantsIBA 01/2024 - 07/2009
9	Vitamin K FDA Link 01/2024 - 09/2008
7	fibrin fragment D (D-dimer)IBA 11/2022 - 02/2008
7	Warfarin (Coumadin)FDA LinkGeneric 07/2022 - 07/2015
4	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 11/2023 - 01/2009
4	apixabanIBA 10/2022 - 02/2014
4	RivaroxabanIBA 01/2022 - 06/2013
4	Dabigatran FDA Link 08/2018 - 06/2013
3	Biomarkers (Surrogate Marker)IBA 07/2022 - 02/2008
3	VaccinesIBA 01/2021 - 01/2021
2	Factor Xa InhibitorsIBA 11/2023 - 06/2013
2	edoxabanIBA 07/2022 - 07/2021
2	ChAdOx1 nCoV-19IBA 01/2021 - 01/2021
2	Oxygen (Dioxygen)IBA 04/2020 - 08/2017
2	Thrombin FDA Link 02/2014 - 06/2013
2	Prothrombin (Factor II)IBA 06/2013 - 09/2010
1	LDL CholesterolIBA 10/2023
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2023
1	eicosapentaenoic acid ethyl esterIBA 10/2023
1	4- ((1,4,8,11- tetraazacyclotetradec- 1- yl)methyl)benzoic acidIBA 11/2022
1	Dalteparin (Dalteparin Sodium)FDA Link 01/2022
1	Intravenous Immunoglobulins (IVIG)FDA Link 01/2021
1	argatroban (MPQA)FDA Link 01/2021
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	AntigensIBA 01/2021
1	Combined Oral ContraceptivesIBA 10/2020
1	vinyltriethoxysilane (VTES)IBA 10/2020
1	tributyl phosphate (TBP)IBA 04/2020
1	Lenalidomide (CC 5013)FDA Link 01/2019
1	Thalidomide (Thalomid)FDA Link 01/2019
1	Immunomodulating AgentsIBA 01/2019
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 12/2018
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 07/2018
1	Antiphospholipid AntibodiesIBA 01/2018
1	Fibrinogen (Factor I)FDA Link 04/2017
1	prothrombin complex concentrates (PPSB)IBA 01/2017
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 09/2015
1	Clopidogrel (Plavix)FDA Link 11/2014
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 11/2014
1	Factor IIaIBA 02/2014
1	Factor Xa (Coagulation Factor Xa)IBA 02/2014
1	anti-inhibitor coagulant complexIBA 06/2013
1	Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA 09/2012
1	Heparin (Liquaemin)FDA LinkGeneric 12/2011
1	C-Reactive ProteinIBA 10/2011
1	shark cartilage extractIBA 07/2011
1	Plasminogen Activators (Plasminogen Activator)IBA 07/2011
1	Fibrinolysin FDA Link 07/2011
1	HomocysteineIBA 10/2009
1	Factor VIII (Coagulation Factor VIII)IBA 04/2006
1	Factor VIIa (Activated Factor VII)IBA 01/2005
1	recombinant FVIIa (rFVIIa)FDA Link 01/2005

Therapy/Procedure

11	Therapeutics 01/2021 - 01/2004
2	Aftercare (After-Treatment) 01/2020 - 01/2019
1	Exercise Therapy (Therapy, Exercise) 04/2021
1	Secondary Prevention 12/2018
1	Ambulatory Care (Outpatient Care) 07/2018
1	Cell- and Tissue-Based Therapy (Cell Therapy) 10/2017
1	Critical Care (Surgical Intensive Care) 09/2017
1	Duration of Therapy 03/2017
1	Surgical Amputation (Amputations) 11/2014
1	Subacute Care 12/2006
1	Compression Stockings 12/2006